These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38088541)

  • 1. The type III secretion system facilitates systemic infections of
    Wu T; Zhang Z; Li T; Dong X; Wu D; Zhu L; Xu K; Zhang Y
    Microbiol Spectr; 2024 Jan; 12(1):e0222423. PubMed ID: 38088541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial Resistance and Type III Secretion System Virulotypes of Pseudomonas aeruginosa Isolates from Dogs and Cats in Primary Veterinary Hospitals in Japan: Identification of the International High-Risk Clone Sequence Type 235.
    Hayashi W; Izumi K; Yoshida S; Takizawa S; Sakaguchi K; Iyori K; Minoshima KI; Takano S; Kitagawa M; Nagano Y; Nagano N
    Microbiol Spectr; 2021 Oct; 9(2):e0040821. PubMed ID: 34585944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudomonas aeruginosa Antivirulence Strategies: Targeting the Type III Secretion System.
    Goldberg JB; Crisan CV; Luu JM
    Adv Exp Med Biol; 2022; 1386():257-280. PubMed ID: 36258075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difference of Type 3 secretion system (T3SS) effector gene genotypes (exoU and exoS) and its implication to antibiotics resistances in isolates of Pseudomonas aeruginosa from chronic otitis media.
    Park MH; Kim SY; Roh EY; Lee HS
    Auris Nasus Larynx; 2017 Jun; 44(3):258-265. PubMed ID: 27461174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and Environmental Investigation of a Novel Phenylamino Acetamide Inhibitor of the Pseudomonas aeruginosa Type III Secretion System.
    Fang L; Banerjee B; Yuan X; Zeng Q; Liang C; Chen X; Yang CH
    Appl Environ Microbiol; 2023 Jan; 89(1):e0175222. PubMed ID: 36519869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on Virulence Genes of Type III Secretion System of Pseudomonas aeruginosa in Xinjiang Province.
    Yi H; Sun Q; Wang X; Liu Y; Feng N; Zhang L; Song W; Shang X; Li X; Ma X
    Clin Lab; 2021 Aug; 67(8):. PubMed ID: 34383413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of ST463
    Zhu Y; Kang Y; Zhang H; Yu W; Zhang G; Zhang J; Kang W; Duan S; Xu Y; Yang Q
    Microbiol Spectr; 2023 Aug; 11(4):e0010523. PubMed ID: 37314344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 3 secretion system effector genotype and secretion phenotype of longitudinally collected Pseudomonas aeruginosa isolates from young children diagnosed with cystic fibrosis following newborn screening.
    Hu H; Harmer C; Anuj S; Wainwright CE; Manos J; Cheney J; Harbour C; Zablotska I; Turnbull L; Whitchurch CB; Grimwood K; Rose B;
    Clin Microbiol Infect; 2013 Mar; 19(3):266-72. PubMed ID: 22329595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudomonas aeruginosa Citrate Synthase GltA Influences Antibiotic Tolerance and the Type III Secretion System through the Stringent Response.
    Chen H; Gong X; Fan Z; Xia Y; Jin Y; Bai F; Cheng Z; Pan X; Wu W
    Microbiol Spectr; 2023 Feb; 11(1):e0323922. PubMed ID: 36602339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of loop-mediated isothermal amplification assays for genotyping of Type III Secretion System in Pseudomonas aeruginosa.
    Shi H; Chen Z; Kan J
    Lett Appl Microbiol; 2015 Oct; 61(4):361-6. PubMed ID: 26219625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular detection of type III secretory toxins in Pseudomonas aeruginosa isolates.
    Jarjees KK
    Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):9-14. PubMed ID: 33040805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Virulence Genes Associated with Type III Secretion System and Biofilm Formation in Pseudomonas aeruginosa Clinical Isolates.
    Ali ASBE; Ozler B; Baddal B
    Curr Microbiol; 2023 Oct; 80(12):389. PubMed ID: 37880467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Psychrotrophic Pseudomonas lundensis, a Non-
    Ravi K; Falkowski NR; Scales BS; Akulava VD; Valentovich LN; Huffnagle GB
    mBio; 2022 Feb; 13(1):e0386921. PubMed ID: 35189702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weighting the impact of virulence on the outcome of Pseudomonas aeruginosa bloodstream infections.
    Sánchez-Diener I; Zamorano L; Peña C; Ocampo-Sosa A; Cabot G; Gómez-Zorrilla S; Almirante B; Aguilar M; Granados A; Calbo E; Rodriguez-Baño J; Rodríguez-López F; Tubau F; Martínez-Martínez L; Navas A; Oliver A
    Clin Microbiol Infect; 2020 Mar; 26(3):351-357. PubMed ID: 31288102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay among Resistance Profiles, High-Risk Clones, and Virulence in the Caenorhabditis elegans Pseudomonas aeruginosa Infection Model.
    Sánchez-Diener I; Zamorano L; López-Causapé C; Cabot G; Mulet X; Peña C; Del Campo R; Cantón R; Doménech-Sánchez A; Martínez-Martínez L; Arcos SC; Navas A; Oliver A
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections.
    Peña C; Cabot G; Gómez-Zorrilla S; Zamorano L; Ocampo-Sosa A; Murillas J; Almirante B; Pomar V; Aguilar M; Granados A; Calbo E; Rodríguez-Baño J; Rodríguez-López F; Tubau F; Martínez-Martínez L; Oliver A;
    Clin Infect Dis; 2015 Feb; 60(4):539-48. PubMed ID: 25378459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exoenzyme Y Contributes to End-Organ Dysfunction Caused by
    Wagener BM; Anjum N; Christiaans SC; Banks ME; Parker JC; Threet AT; Walker RR; Isbell KD; Moser SA; Stevens T; Alexeyev MF; Audia JP; Richter W; Hardy KS; Saleh LA; Morgan C; Pittet JF
    Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32512716
    [No Abstract]   [Full Text] [Related]  

  • 18. Chimeric Protein-Protein Interface Inhibitors Allow Efficient Inhibition of Type III Secretion Machinery and
    Ngo TD; Plé S; Thomas A; Barette C; Fortuné A; Bouzidi Y; Fauvarque MO; Pereira de Freitas R; Francisco Hilário F; Attrée I; Wong YS; Faudry E
    ACS Infect Dis; 2019 Nov; 5(11):1843-1854. PubMed ID: 31525902
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel type III effectors in Pseudomonas aeruginosa.
    Burstein D; Satanower S; Simovitch M; Belnik Y; Zehavi M; Yerushalmi G; Ben-Aroya S; Pupko T; Banin E
    mBio; 2015 Mar; 6(2):e00161. PubMed ID: 25784698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TpiA is a Key Metabolic Enzyme That Affects Virulence and Resistance to Aminoglycoside Antibiotics through CrcZ in Pseudomonas aeruginosa.
    Xia Y; Wang D; Pan X; Xia B; Weng Y; Long Y; Ren H; Zhou J; Jin Y; Bai F; Cheng Z; Jin S; Wu W
    mBio; 2020 Jan; 11(1):. PubMed ID: 31911486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.